GlassScriptPhysician profile
Audrey L Cabe
NPI 1366870925
$1,219.99
in general payments reported to CMS, 2019-2025
13 companies · $292 in 2025
The $292 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $129 · 2022: $176 · 2023: $175 · 2024: $448 · 2025: $292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $915.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $914.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $277.30 | 2023-2025 | Libtayo, Dupixent |
| Boston Scientific Corporation | $252.81 | 2024-2025 | Superion Indirect Decompression System, Wavewriter Alpha Prime 16, Coveredge 32 |
| Baxter Healthcare | $213.14 | 2021-2024 | Floseal |
| Aerin Medical INC. | $172.25 | 2024-2025 | |
| Stryker Corporation | $75.09 | 2021-2023 | Adherus Autospray Dural Sealant |
| Sk Life Science, INC. | $58.99 | 2021 | |
| Genzyme Corporation | $40.20 | 2025 | |
| Hikma Pharmaceuticals USA | $35.86 | 2025 | Ryaltris |
| Lemaitre Vascular, INC. | $28.85 | 2022-2023 | Anastoclip Gc 8cm (Medium) |
| Glaxosmithkline, LLC. | $18.99 | 2024 | Nucala |
| Csl Behring | $16.70 | 2021 | |
| Integra Lifesciences Corporation | $16.00 | 2022 | |
| Alexion Pharmaceuticals, INC. | $13.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Audrey Cabe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.